← All news
Markets
H.C. Wainwright raises Zymeworks stock price target to $55 on FDA approval
Covered by 1 outlet
All coverage · 3 articles
Investing.com UK
·Aug 26, 21:50 UTC
Oppenheimer raises Revolution stock price target on FDA approval
Investing.com Canada
·Aug 26, 11:38 UTC
H.C. Wainwright raises Zymeworks stock price target to $55 on FDA approval
Investing.com News
·Aug 26, 11:37 UTC